porosis is primarily a disease of females and its epidemiology differs between the genders, this article will focus on these 17.5 million females.
The data indicate a fertile field for an information initiative to publicize the bone density screening benefit, both to physicians who ought to be talking to more of their patients about osteoporosis, and to patients who should know more about the disease, the screening tests, and the Medicare benefit.
SCREENING FOR COLORECTAL CANCER
Colorectal cancer is second only to lung cancer in causing cancer-related deaths in the U.S., accounting for 55,000 deaths a year. It is largely a disease of people age 50 or over, and the risk increases with age. The early progression of the disease is largely asymptomatic: about 60 percent of patients with colorectal cancer have regional or distant metastases at the time of diagnosis.
Sur vival is markedly improved by detecting the disease at an early stage (U.S. Preventive Services Task Force, 1996) . According to the MCBS, about 3 percent of the Medicare aged report having been diagnosed with colon cancer.
Detection of colorectal cancer is via several types of screening tests, all of which are aimed at finding evidence of cancerous or precancerous growths. The most useful of these for population screening are: fecal occult blood testing and sigmoidoscopy. 1 The following are screening tests for colorectal cancer: digital rectal exam, fecal occult blood test (FOBT), sigmoidoscopy, colonoscopy, and barium enema.
Medicare covers a FOBT once a year under Part B, with no coinsurance or deductible. FOBT is given to the patient as a card with spaces for stool samples, which are collected at home. The samples are then sent to the doctor's office or a laboratory to be tested for the presence of hidden (occult) blood.
Medicare covers a sigmoidoscopy once every 4 years, subject to a 20-percent copayment after the Part B deductible is met. In this test the doctor visualizes the lower third of the colon (large intestine) through a flexible lighted tube, checking for cancerous lesions or polyps, which may be precancerous. This is usually done in the doctor's office. A colonoscopy is similar, using a longer tube to see more of the colon. Since it is more invasive, the procedure is often done in a hospital under anesthesia. Medicare covers a colonoscopy every 2 years for persons at high risk, otherwise every 10 years.
• In this population, 23 percent report ever having been told by a doctor that they had osteoporosis.
• Another 26 percent had not been diagnosed, though they had talked with a doctor about the disease.
• The remaining 51 percent had never talked to a doctor about osteoporosis.
• Given the high frequency of this condition, the proportion who had not discussed it with their doctor seems quite high.
Never Talked 51%
Not Told 26%
Told Had 23% • Many of those who had the test had it relatively recently; 75 percent had it within the 2 years before the interview-roughly since the Medicare benefit began. • Just as knowledge about the test is low, knowledge that Medicare pays for bone density tests is very low. Of those who have not had the test, only 30 percent know that Medicare will pay some of the cost of these screening tests. • One-half of the population has ever had a sigmoidoscopy or colonoscopy.
• Thirty-two percent did not have the test but heard of it, while the remaining 18 percent had neither had it nor heard of it.
Have • The rates for the combination of the two tests: 18 percent of the population have had FOBT only, another 18 percent sigmoidoscopy/colonoscopy only, 31 percent have had both, and 33 percent have had neither. • We can assert that two thirds of the community-dwelling Medicare population age 65 or over have had some kind of screening for colon cancer, but concern arises for the onethird who have not. 
